The largest community of pharma leaders

CTD Appoints Head of Global Regulatory Affairs

ALACHUA, Fla.–(BUSINESS WIRE)–CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, today announced the appointment of Mr. Michael Lisjak as Global Head of Regulatory Affairs and Senior Vice President for Business Development. CTD’s Chairman and CEO N. Scott Fine said, “As our company expands, we are pleased to add Michael to our executive team. His wealth of experience in global….

 

 

http://www.businesswire.com/news/home/20190708005143/en/CTD-Appoints-Head-Global-Regulatory-Affairs

Recent Articles

Shape Therapeutics to Present Groundbreaking Advances in ADAR-Mediated RNA Editing in Parkinson’s Disease at the Jefferies Gene Therapy and Editing Summit

SEATTLE--(BUSINESS WIRE)--Shape Therapeutics, Inc. (ShapeTX), a pre-clinical stage company with an...

Health Canada Approves REBLOZYL® (luspatercept), New Class of Treatment for Adult Patients Living with Beta Thalassemia

MONTREAL & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bristol Myers Squibb Canada (BMS) and Acceleron...

Orb Health Names Healthcare Visionary Entrepreneur and Investor Sheila Schweitzer to Board of Directors

RICHARDSON, Texas.--(BUSINESS WIRE)-- #aco--Orb Health, the leader in Chronic Care Management...

Fierce Biotech Names Accent Therapeutics as One of Its “Fierce 15” Biotech Companies of 2020

LEXINGTON, Mass.--(BUSINESS WIRE)--Accent Therapeutics today announced that it has been named...

Fierce Biotech Names Amylyx Pharmaceuticals as One of Its “Fierce 15” Biotech Companies of 2020

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals today announced that it has been named...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.